Michael E Dobson

Title: Michael E Dobson: Innovator in Vaccine Development

Introduction

Michael E Dobson is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of vaccine development, particularly in relation to rickettsial infections. His work has implications for both vaccination and diagnostic methods.

Latest Patents

Michael E Dobson holds a patent for a gene and protein applicable to the preparation of vaccines. This patent involves the DNA sequence of the gene encoding the S-layer protein of R. prowazekii, as well as a truncated identical piece of this gene in R. typhi. The invention aims to provide a means for vaccination against typhus and spotted fever rickettsial infections, as well as for diagnosing diseases caused by these bacteria. The patent also includes the deduced amino acid sequence of the S-layer protein derived from the DNA sequence.

Career Highlights

Michael E Dobson works for the United States as represented by the Secretary of the Navy. His role involves significant research and development efforts in the field of infectious diseases and vaccine technology. He has been instrumental in advancing the understanding of rickettsial pathogens and their associated diseases.

Collaborations

Michael has collaborated with notable colleagues, including Mitchell Carl and Wei-Mei Ching. These collaborations have furthered the research and development of innovative solutions in vaccine technology.

Conclusion

Michael E Dobson is a key figure in the field of vaccine innovation, with a focus on rickettsial infections. His contributions through patents and collaborations highlight the importance of research in combating infectious diseases. His work continues to pave the way for advancements in vaccine development.